½ÃÀ庸°í¼­
»óǰÄÚµå
1575460

¼¼°èÀÇ °­³» Æ®·£½ºµà¼­ ½ÃÀå : Á¦Ç° À¯Çü, ±â¼ú, ÇÁ·Îºê Á֯ļö, ȯÀÚ ¿¬·ÉÃþ, ÃÖÁ¾ »ç¿ëÀÚ, ¿ëµµº° ¿¹Ãø(2025-2030³â)

Endocavity Transducer Market by Product Type, Technology, Probe Frequency, Patient Age Group, End Users, Application - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 197 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

°­³» Æ®·£½ºµà¼­ ½ÃÀåÀº 2023³â¿¡ 37¾ï 1,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 38¾ï 9,000¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 4.05%·Î ¼ºÀåÇØ 2030³â¿¡´Â 49¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°­³» Æ®·£½ºµà¼­ ½ÃÀåÀº °æÁ÷Àå ¹× °æÁú À̹Ì¡À» Æ÷ÇÔÇÑ ³»ºÎ °Ë»ç¸¦ À§ÇØ Æ¯º°È÷ ¼³°èµÈ ÃÊÀ½ÆÄ ÀåÄ¡ÀÇ °³¹ß°ú »ç¿ëÀ» Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Æ®·£½ºµà¼­´Â Àü¸³¼±, Àڱà ¹× ±âŸ °ñ¹Ý ³»Àå±â¿Í °ü·ÃµÈ Áúº´ÀÇ Áø´Ü ¹× Ä¡·á¸¦ À§ÇØ °íÇØ»óµµ À̹ÌÁö¸¦ Á¦°øÇÏ´Â µ¥ ÇʼöÀûÀ̹ǷΠ»ê°ú, ºÎÀΰú, ºñ´¢±â°ú µîÀÇ ¿ëµµ ¿¡ ÇʼöÀûÀÔ´Ï´Ù. ½ÃÀåÀÇ Çʿ伺Àº Àü¸³¼± ¾Ï°ú ºÎÀΰú Áúȯ Áõ°¡, Á¶±â Áø´ÜÀ» ÃËÁøÇÏ´Â ÀÇ½Ä Çâ»ó ÇÁ·Î±×·¥¿¡ ÀÇÇØ Á¦°øµË´Ï´Ù. ÁÖ¿ä ¿ëµµ´Â ¾Ï °ËÃâ, ÅÂ¾Æ °Ç°­ ¸ð´ÏÅ͸µ, »ý½Ä °Ç°­ Æò°¡ÀÔ´Ï´Ù. ÃÖÁ¾ ¿ëµµ¿¡´Â ÁÖ·Î º´¿ø, Áø´Ü¼¾ÅÍ, Àü¹® Ŭ¸®´ÐÀÌ Æ÷ÇԵ˴ϴÙ. ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â 3D/4D À̹Ì¡ ±â´ÉÀ̳ª ¼ÒÇüÈ­ ÇÁ·Îºê µîÀÇ ±â¼úÀû Áøº¸¸¦ µé ¼ö ÀÖÀ¸¸ç, À̷νá È­»ó Á¤¹Ðµµ°¡ Çâ»óµÇ°í ȯÀÚÀÇ ÄèÀû¼ºÀÌ Çâ»óµÇ±â ¶§¹®¿¡ ä¿ë·üÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ¼±Áø±¹°ú ½ÅÈï°æÁ¦±¹¿¡¼­ ÇコÄɾî ÁöÃâ Áõ°¡¿Í ±Þ¼ÓÇÑ °í·ÉÈ­°¡ ½ÃÀå È®´ë¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª °í¾×ÀÇ Àåºñ ºñ¿ë, ¿î¿µÀÚÀÇ ½Àµæ °î¼±ÀÇ ÇèÇÔ, ¶§·Î´Â ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç µîÀÇ °úÁ¦°¡ ¼ºÀåÀ» ¹æÇØÇÒ ¼öµµ ÀÖ½À´Ï´Ù. ½ÃÀå ±âȸ¸¦ Ȱ¿ëÇϱâ À§ÇØ ±â¾÷Àº AI¸¦ Ȱ¿ëÇÑ ¿¹Ãø À̹Ì¡, ÈÞ´ë¿ë ¹«¼± Æ®·£½ºµà¼­ ¼³°è, °¡°Ý¿¡ ¹Î°¨ÇÑ ½ÃÀå¿¡ ´ëÀÀÇϱâ À§ÇÑ ºñ¿ë È¿À²ÀûÀÎ Á¦Á¶ ±â¼ú µîÀÇ Çõ½Å¿¡ ÁÖ·ÂÇØ¾ß ÇÕ´Ï´Ù. ¶ÇÇÑ ÆÇ¸Å¸Á È®´ë ¹× Á¦Ç° Æ÷Æ®Æú¸®¿À È®´ë¸¦ À§ÇÑ Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ±ÇÀåÇÕ´Ï´Ù. ¼÷·ÃµÈ Àü¹®°¡¿¡ ´ëÇÑ ÀÇÁ¸°ú ȯÀÚÀÇ ºÒÄè°¨ÀÇ °¡´É¼º µîÀÇ ÇѰè´Â Á¾ÇÕÀûÀÎ »ç¿ëÀÚ Æ®·¹ÀÌ´× ÇÁ·Î±×·¥ ¹× Æ®·£½ºµà¼­ ¼³°è¿¡ À־ÀÇ ÀÎü°øÇÐÀû Áøº¸·Î ´ëÃ³ÇØ¾ß ÇÕ´Ï´Ù. ½ÃÀå ¿ªÇÐÀº ¿ªµ¿ÀûÀ̸ç, Ä¡¿­ÇÑ °æÀï°ú Áö¼ÓÀûÀÎ R&D ³ë·ÂÀÌ ÇöÀúÇϸç, ƯÈ÷ ºñħ½À Áø´Ü µµ±¸¿Í ¿ø°Ý ÀÇ·á ÅëÇÕ¿¡¼­ ±â¼ú Çõ½ÅÀ» À§ÇÑ ºñ¿ÁÇÑ ¿µ¿ªÀ» °¡¸®Å°°í ÀÖ½À´Ï´Ù. ±â¾÷Àº ½ÃÀå ħÅõ¿Í »ç¿ëÀÚ ½Å·Ú¸¦ ³ôÀ̱â À§ÇØ ¼ÒºñÀÚ ±³À°À» ¿ì¼±½ÃÇϰí ȯÀÚ¿¡°Ô Ä£¼÷ÇÑ Áøº¸¸¦ °­Á¶ÇؾßÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 37¾ï 1,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 38¾ï 9,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 49¾ï 1,000¸¸ ´Þ·¯
CAGR(%) 4.05%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â °­³» Æ®·£½ºµà¼­ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

°­³» Æ®·£½ºµà¼­ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿Àû ÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ðÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû °áÁ¤ Á¤¹ÐÈ­, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¶Ç´Â ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ºÒÀÓ Ä¡·á Ŭ¸®´ÐÀ̳ª »ý½Ä ÀÇ·á ¼¾ÅÍ¿¡ À־ÀÇ °­³» º¯È¯±â ¼ö¿ä ±ÞÁõ
    • ÇコÄɾî ÀÎÇÁ¶ó È®´ë¿Í ½ÅÈï ½ÃÀå ÅõÀÚ Áõ°¡
    • °í±Þ ÀÇ·á ÀýÂ÷¿¡¼­ 3D ¹× 4D °­³» Æ®·£½ºµà¼­ äÅà Áõ°¡
    • Çコ ÄɾÀÇ ¾×¼¼½º¿Í ÇÕ¸®ÀûÀÎ °¡°ÝÀ» Áö¿øÇÏ´Â Á¤ºÎÀÇ ´ëó°¡ ÃÊÀ½ÆÄ ÀåÄ¡ÀÇ Ã¤¿ëÀ» µÞ¹Þħ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • °­³» Æ®·£½ºµà¼­ ±â±âÀÇ Á¶ÀÛ¿¡ ¼÷·ÃµÈ Àü¹®°¡°¡ ÇÑÁ¤µÇ¾î ÀÖ´Â °Í
    • °­³» Æ®·£½ºµà¼­ ±â¼ú°ú °ü·ÃµÈ ±â¼úÀû ÇѰè¿Í ½Å·Ú¼º¿¡ ´ëÇÑ ¿ì·Á
  • ½ÃÀå ±âȸ
    • °­³» Æ®·£½ºµà¼­ÀÇ º¸±ÞÀ» ÃËÁøÇÏ´Â ½ÅÈï±¹ÀÇ Çコ Äɾî ÀÎÇÁ¶ó¿Í ¾×¼¼½ºÀÇ °³¼±
    • Àü¸³¼±¾ÏÀ̳ª ÀڱðæºÎ¾ÏÀÇ Á¶±â ¹ß°ß¿¡ ´ëÇÑ ÀǽÄÀÇ °íÁ¶¿Í °ËÁø ÇÁ·Î±×·¥
    • ÃÊÀ½ÆÄ ·ç¸à ±â¼ú¿¡¼­ ÀΰøÁö´É°ú ¸Ó½Å·¯´×ÀÇ ÅëÇÕ
  • ½ÃÀåÀÇ °úÁ¦
    • °­³» Æ®·£½ºµà¼­ ½ÃÀå¿¡¼­ÀÇ Áö¼ÓÀûÀÎ ¾÷±×·¹À̵å¿Í ¿î¿µ ºñ¿ë Áõ°¡¸¦ ÇÊ¿ä·Î ÇÏ´Â ±â¼úÀÇ Áøº¸

Portre's Five Forces: °­³» Æ®·£½ºµà¼­ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â °­³» Æ®·£½ºµà¼­ ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Force Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂûÀ» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : °­³» Æ®·£½ºµà¼­ ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½ÃÀû ȯ°æ ¿äÀÎÀº Á¾´Ü °øµ¿ º¯È¯±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇϴµ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : °­³» Æ®·£½ºµà¼­ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

°­³» Æ®·£½ºµà¼­ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : °­³» Æ®·£½ºµà¼­ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â °­³» Æ®·£½ºµà¼­ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå : °­³» Æ®·£½ºµà¼­ ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

°­³» Æ®·£½ºµà¼­ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ Á¸À縦 °­È­ÇÏ·Á´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ´É·Â ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ºÒÀÓÄ¡·á Ŭ¸®´ÐÀ̳ª »ý½ÄÀÇ·á¼¾ÅÍ¿¡ À־ÀÇ °­³» Æ®·£½ºµà¼­ ¼ö¿ä ±ÞÁõ
      • ÇコÄɾî ÀÎÇÁ¶ó È®´ë¿Í ½ÅÈï ½ÃÀå ÅõÀÚ Áõ°¡
      • °í±Þ ÀÇ·á ÀýÂ÷¿¡¼­ 3D ¹× 4D ·ç¸à Æ®·£½º µà¼­ äÅà Áõ°¡
      • Çコ ÄɾÀÇ ¾×¼¼½º¿Í ÇÕ¸®ÀûÀÎ °¡°ÝÀ» Áö¿øÇÏ´Â Á¤ºÎÀÇ ´ëó¿¡ ÀÇÇØ ÃÊÀ½ÆÄ ±â±âÀÇ µµÀÔÀÌ ÃËÁøµÈ´Ù
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
      • °­³» Æ®·£½ºµà¼­ µð¹ÙÀ̽º¸¦ Á¶ÀÛÇÏ´Â ¼÷·ÃµÈ Àü¹®°¡°¡ ÇÑÁ¤µÇ¾î ÀÖ´Ù
      • °­³» Æ®·£½ºµà¼­ ±â¼ú°ú °ü·ÃµÈ ±â¼úÀû Á¦ÇÑ ¹× ½Å·Ú¼º¿¡ ´ëÇÑ ¿ì·Á
    • ±âȸ
      • ½ÅÈï °æÁ¦±¹ÀÇ Çコ Äɾî ÀÎÇÁ¶ó¿Í ¾×¼¼½ºÀÇ °³¼±ÀÌ °­³» Æ®·£½ºµà¼­ÀÇ Ã¤¿ëÀ» ÃËÁø
      • Àü¸³¼±¾Ï°ú ÀڱðæºÎ¾ÏÀÇ Á¶±â ¹ß°ß¿¡ ´ëÇÑ Àǽİú °Ë»ç ÇÁ·Î±×·¥ÀÇ È®´ë
      • °­³» ÃÊÀ½ÆÄ ±â¼ú¿¡¼­ ÀΰøÁö´É°ú ¸Ó½Å·¯´×ÀÇ ÅëÇÕ
    • °úÁ¦
      • ±â¼úÀÇ ¹ßÀüÀ¸·Î Áö¼ÓÀûÀÎ ¾÷±×·¹À̵尡 ÇÊ¿äÇÏ¸ç ¿î¿µ ºñ¿ëÀÌ Áõ°¡ÇÕ´Ï´Ù.
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »ç±³
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå °­³» Æ®·£½ºµà¼­ ½ÃÀå : Á¦Ç° À¯Çüº°

  • º¼·Ï ¾î·¹ÀÌ Æ®·£½ºµà¼­
  • ¸®´Ï¾î ¾î·¹ÀÌ Æ®·£½ºµà¼­
  • ÆäÀÌÁîµå ¾î·¹ÀÌ Æ®·£½ºµà¼­

Á¦7Àå °­³» Æ®·£½ºµà¼­ ½ÃÀå : ±â¼úº°

  • 2D À̹Ì¡
    • °í±Þ 2D À̹Ì¡
    • ±âº» 2D À̹Ì¡
  • 3D/4D À̹Ì¡
    • °í±Þ 3D À̹Ì¡
    • ±âº» 3D À̹Ì¡
  • µµÇ÷¯ À̹ÌÁö
    • ¿¬¼ÓÆÄ µµÇ÷¯
    • ÆÞ½ºÆÄ µµÇ÷¯

Á¦8Àå °­³» Æ®·£½ºµà¼­ ½ÃÀå : ÇÁ·Îºê Á֯ļöº°

  • °íÁÖÆÄ
  • ÀúÁÖÆÄ
  • ÁßÁÖÆÄ

Á¦9Àå °­³» Æ®·£½ºµà¼­ ½ÃÀå : ȯÀÚ ¿¬·ÉÃþº°

  • ¼ºÀÎ
    • °í·É
    • û³â
  • ³ë³âÀÇÇÐ
  • ¼Ò¾Æ°ú
    • ¾Æµ¿
    • ½Å»ý¾Æ

Á¦10Àå °­³» Æ®·£½ºµà¼­ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
    • ÇÏÀ§ ºÎ¹® M
    • ÇÏÀ§ ºÎ¹® N
  • Áø´Ü¼¾ÅÍ
    • Áø´Ü °Ë»ç
    • È­»ó °Ë»ç ¼ø¼­
  • º´¿ø
    • ÀÔ¿ø Ä¡·á
    • ¿Ü·¡ Áø·á

Á¦11Àå °­³» Æ®·£½ºµà¼­ ½ÃÀå : ¿ëµµº°

  • ½ÉÀ庴ÇÐ
  • ºÎÀΰú
  • ºñ´¢±â°ú

Á¦12Àå ¾Æ¸Þ¸®Ä«ÀÇ °­³» Æ®·£½ºµà¼­ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦13Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °­³» Æ®·£½ºµà¼­ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦14Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °­³» Æ®·£½ºµà¼­ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦15Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È
JHS 24.10.30

The Endocavity Transducer Market was valued at USD 3.71 billion in 2023, expected to reach USD 3.89 billion in 2024, and is projected to grow at a CAGR of 4.05%, to USD 4.91 billion by 2030.

The endocavity transducer market encompasses the development and use of ultrasound devices specifically designed for internal examinations, including transrectal and transvaginal imaging. These transducers are essential in providing high-resolution images for the diagnosis and treatment of conditions related to the prostate, uterus, and other pelvic organs, thus being indispensable in applications such as obstetrics, gynecology, and urology. Market necessity is driven by increasing incidences of prostate cancer, gynecological disorders, and rising awareness programs promoting early diagnosis. Key applications are cancer detection, fetal health monitoring, and reproductive health assessments. The end-use scope primarily includes hospitals, diagnostic centers, and specialty clinics. Among the key growth influencers are technological advancements, such as 3D/4D imaging capabilities and miniaturized probes, which enhance image accuracy and patient comfort, thereby driving adoption rates. Additionally, increasing healthcare expenditures and rapid aging demographics across developed and emerging economies foster market expansion. However, challenges like high device costs, a steep learning curve for operators, and sometimes stringent regulatory requirements can hamper growth. To capitalize on market opportunities, companies should focus on innovations like AI-driven predictive imaging, portable and wireless transducer designs, and cost-effective manufacturing technologies to cater to price-sensitive markets. Furthermore, strategic partnerships for expanding distribution networks and broadening product portfolios are recommended. Limitations such as a dependence on skilled professionals and potential for patient discomfort should be addressed with comprehensive user training programs and ergonomic advancements in transducer design. The market is dynamic, marked by intense competition and continuous research and development efforts, pointing towards a fertile area for innovation, especially in non-invasive diagnostic tools and telemedicine integration. Firms should prioritize consumer education and emphasize patient-friendly advancements to enhance both market penetration and user trust.

KEY MARKET STATISTICS
Base Year [2023] USD 3.71 billion
Estimated Year [2024] USD 3.89 billion
Forecast Year [2030] USD 4.91 billion
CAGR (%) 4.05%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Endocavity Transducer Market

The Endocavity Transducer Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Surge in demand for endocavity transducers in fertility clinics and reproductive health centers
    • Expansion of healthcare infrastructure and increasing investment in emerging markets
    • Increasing adoption of 3D and 4D endocavity transducers in advanced medical procedures
    • Government initiatives supporting healthcare access and affordability boosting ultrasound device adoption
  • Market Restraints
    • Limited availability of skilled professionals for operating endocavity transducer devices
    • Technical limitations and reliability concerns associated with endocavity transducer technology
  • Market Opportunities
    • Improving healthcare infrastructure and access in emerging economies driving endocavity transducer adoption
    • Growing awareness and screening programs for early detection of prostate and cervical cancers
    • Integration of artificial intelligence and machine learning in endocavity ultrasound technologies
  • Market Challenges
    • Technological advancements requiring continuous upgrades and increasing operational costs in endocavity transducer market

Porter's Five Forces: A Strategic Tool for Navigating the Endocavity Transducer Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Endocavity Transducer Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Endocavity Transducer Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Endocavity Transducer Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Endocavity Transducer Market

A detailed market share analysis in the Endocavity Transducer Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Endocavity Transducer Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Endocavity Transducer Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Endocavity Transducer Market

A strategic analysis of the Endocavity Transducer Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Endocavity Transducer Market, highlighting leading vendors and their innovative profiles. These include Analogic Corporation, BK Medical, Canon Medical Systems, Carestream Health, Chison Medical Imaging, Cook Medical, Esaote SpA, Fujifilm Holdings Corporation, GE Healthcare, Hitachi Ltd., Hologic Inc., KOELIS, Medtronic, Mindray Medical International, Philips Healthcare, Samsung Medison, Shenzhen Emperor Electronic Technology, Siemens Healthineers, Sonosite Inc., and SuperSonic Imagine.

Market Segmentation & Coverage

This research report categorizes the Endocavity Transducer Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Convex Array Transducers, Linear Array Transducers, and Phased Array Transducers.
  • Based on Technology, market is studied across 2D Imaging, 3D/4D Imaging, and Doppler Imaging. The 2D Imaging is further studied across Advanced 2D Imaging and Basic 2D Imaging. The 3D/4D Imaging is further studied across Advanced 3D Imaging and Basic 3D Imaging. The Doppler Imaging is further studied across Continuous Wave Doppler and Pulsed Wave Doppler.
  • Based on Probe Frequency, market is studied across High Frequency, Low Frequency, and Medium Frequency.
  • Based on Patient Age Group, market is studied across Adults, Geriatrics, and Pediatrics. The Adults is further studied across Older Adults and Young Adults. The Pediatrics is further studied across Children and Neonates.
  • Based on End Users, market is studied across Ambulatory Surgical Centers, Diagnostic Centers, and Hospitals. The Ambulatory Surgical Centers is further studied across Sub-segment M and Sub-segment N. The Diagnostic Centers is further studied across Diagnostic Testing and Imaging Procedures. The Hospitals is further studied across Inpatient Care and Outpatient Care.
  • Based on Application, market is studied across Cardiology, Gynecology, and Urology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surge in demand for endocavity transducers in fertility clinics and reproductive health centers
      • 5.1.1.2. Expansion of healthcare infrastructure and increasing investment in emerging markets
      • 5.1.1.3. Increasing adoption of 3D and 4D endocavity transducers in advanced medical procedures
      • 5.1.1.4. Government initiatives supporting healthcare access and affordability boosting ultrasound device adoption
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of skilled professionals for operating endocavity transducer devices
      • 5.1.2.2. Technical limitations and reliability concerns associated with endocavity transducer technology
    • 5.1.3. Opportunities
      • 5.1.3.1. Improving healthcare infrastructure and access in emerging economies driving endocavity transducer adoption
      • 5.1.3.2. Growing awareness and screening programs for early detection of prostate and cervical cancers
      • 5.1.3.3. Integration of artificial intelligence and machine learning in endocavity ultrasound technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Technological advancements requiring continuous upgrades and increasing operational costs in endocavity transducer market
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Endocavity Transducer Market, by Product Type

  • 6.1. Introduction
  • 6.2. Convex Array Transducers
  • 6.3. Linear Array Transducers
  • 6.4. Phased Array Transducers

7. Endocavity Transducer Market, by Technology

  • 7.1. Introduction
  • 7.2. 2D Imaging
    • 7.2.1. Advanced 2D Imaging
    • 7.2.2. Basic 2D Imaging
  • 7.3. 3D/4D Imaging
    • 7.3.1. Advanced 3D Imaging
    • 7.3.2. Basic 3D Imaging
  • 7.4. Doppler Imaging
    • 7.4.1. Continuous Wave Doppler
    • 7.4.2. Pulsed Wave Doppler

8. Endocavity Transducer Market, by Probe Frequency

  • 8.1. Introduction
  • 8.2. High Frequency
  • 8.3. Low Frequency
  • 8.4. Medium Frequency

9. Endocavity Transducer Market, by Patient Age Group

  • 9.1. Introduction
  • 9.2. Adults
    • 9.2.1. Older Adults
    • 9.2.2. Young Adults
  • 9.3. Geriatrics
  • 9.4. Pediatrics
    • 9.4.1. Children
    • 9.4.2. Neonates

10. Endocavity Transducer Market, by End Users

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
    • 10.2.1. Sub-segment M
    • 10.2.2. Sub-segment N
  • 10.3. Diagnostic Centers
    • 10.3.1. Diagnostic Testing
    • 10.3.2. Imaging Procedures
  • 10.4. Hospitals
    • 10.4.1. Inpatient Care
    • 10.4.2. Outpatient Care

11. Endocavity Transducer Market, by Application

  • 11.1. Introduction
  • 11.2. Cardiology
  • 11.3. Gynecology
  • 11.4. Urology

12. Americas Endocavity Transducer Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Endocavity Transducer Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Endocavity Transducer Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Analogic Corporation
  • 2. BK Medical
  • 3. Canon Medical Systems
  • 4. Carestream Health
  • 5. Chison Medical Imaging
  • 6. Cook Medical
  • 7. Esaote SpA
  • 8. Fujifilm Holdings Corporation
  • 9. GE Healthcare
  • 10. Hitachi Ltd.
  • 11. Hologic Inc.
  • 12. KOELIS
  • 13. Medtronic
  • 14. Mindray Medical International
  • 15. Philips Healthcare
  • 16. Samsung Medison
  • 17. Shenzhen Emperor Electronic Technology
  • 18. Siemens Healthineers
  • 19. Sonosite Inc.
  • 20. SuperSonic Imagine
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦